Scarica l'app Stockscreener
6.54
2.35%
0.15
Dopo l'orario di chiusura:
6.54
Entrada Therapeutics Inc Borsa (TRDA) Ultime notizie
Is Entrada Therapeutics Inc. a good long term investmentHigh-impact stock picks - PrintWeekIndia
What analysts say about Entrada Therapeutics Inc. stockUnbelievable profit margins - Autocar Professional
Why Entrada Therapeutics Inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - Newser
How high can Entrada Therapeutics Inc. stock price go in 2025Free Stock Market Return Analysis - jammulinksnews.com
Entrada Therapeutics Inc. Stock Analysis and ForecastPhenomenal investment performance - Autocar Professional
What drives Entrada Therapeutics Inc. stock priceAccelerated earnings growth - Autocar Professional
How Entrada Therapeutics Inc. stock performs during market volatilityFree Stock Trading Signals - Newser
why entrada therapeutics inc. stock attracts strong analyst attentionFree Trading Strategy Suggestions - Newser
What makes Entrada Therapeutics Inc. stock price move sharplyFree Stock Investment Growth Plan - Newser
Allspring Global Investments Holdings LLC Has $149,000 Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Allspring Global Investments Holdings LLC - Defense World
Major Stock Sell-Offs at Entrada Therapeutics: What You Need to Know! - TipRanks
5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k - Investing.com Nigeria
5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k By Investing.com - Investing.com South Africa
Entrada therapeutics (TRDA) director Parmar sells $202k in stock By Investing.com - Investing.com South Africa
Entrada therapeutics (TRDA) director Parmar sells $202k in stock - Investing.com Australia
(TRDA) Investment Analysis and Advice - news.stocktradersdaily.com
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):